Cargando…
Inhibition of Stromal PlGF Suppresses the Growth of Prostate Cancer Xenografts
The growth and vascularization of prostate cancer is dependent on interactions between cancer cells and supporting stromal cells. The primary stromal cell type found in prostate tumors is the carcinoma-associated fibroblast, which produces placental growth factor (PlGF). PlGF is a member of the vasc...
Autores principales: | Zins, Karin, Thomas, Anita, Lucas, Trevor, Sioud, Mouldy, Aharinejad, Seyedhossein, Abraham, Dietmar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3794762/ https://www.ncbi.nlm.nih.gov/pubmed/24005860 http://dx.doi.org/10.3390/ijms140917958 |
Ejemplares similares
-
PlGF and VEGF-A Regulate Growth of High-Risk MYCN-Single Copy Neuroblastoma Xenografts via Different Mechanisms
por: Zins, Karin, et al.
Publicado: (2016) -
A Rac1/Cdc42 GTPase-Specific Small Molecule Inhibitor Suppresses Growth of Primary Human Prostate Cancer Xenografts and Prolongs Survival in Mice
por: Zins, Karin, et al.
Publicado: (2013) -
Adenoviral-Mediated Endothelial Precursor Cell Delivery of Soluble CD115 Suppresses Human Prostate Cancer Xenograft Growth in Mice
por: Lucas, Trevor, et al.
Publicado: (2009) -
PlGF, immune system and hypertension
por: Carnevale, Daniela, et al.
Publicado: (2015) -
Targeting Cdc42 with the small molecule drug AZA197 suppresses primary colon cancer growth and prolongs survival in a preclinical mouse xenograft model by downregulation of PAK1 activity
por: Zins, Karin, et al.
Publicado: (2013)